The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages
Abstract
Our objective was to investigate sym‐pathetic and sensory nerve fibers in synovial tissue in rheumatoid arthritis (RA) and osteoarthritis (OA) in relation to histological inflammation and synovial cytokine and norepinephrine (NE) secretion. Immu‐nohistochemistry was used to detect nerve fibers and inflammatory parameters. A superfusion technique of synovial tissue pieces was used to investigate cytokine and NE secretion. In RA, we detected 0.2 ± 0.04 tyrosine hydroxylase‐positive (TH‐positive=sympathetic) nerve fibers/mm 2 as com‐pared to 4.4 ± 0.8 nerve fibers/mm 2 in OA ( P <0.001). In RA, there was a negative correlation between the number of TH‐positive nerve fibers and inflammation index (R Rank =−0.705, P =0.002) and synovial secretion (R Rank =−0.630, P =0.009), which was not found in OA. Substance P‐positive (=sensory) nerve fibers were increased in RA as compared to OA (3.5 ±0.2 vs. 2.3±0.3/mm 2 , P =0.009). Despite lower numbers of sympathetic nerve fibers in RA than in OA, NE release was similar at baseline (RA vs. OA: 152±36 vs. 106±21 pg/ml, n.s.). Basal synovial NE secretions correlate with the number of TH‐positive CD 163 + synovial macro‐phages (RA: R Rank =0.622, P =0.031; OA: R Rank = 0.299, n.s.), and synovial macrophages have been shown to produce NE in vitro . Whereas sympathetic innervation is reduced, sensory innervation is in‐creased in the synovium from patients with long‐standing RA when compared to the synovium from OA patients. The differential patterns of innervation are dependent on the severity of the inflammation. However, NE secretion from the synovial tissue is maintained by synovial macrophages. This demon‐strates a loss of the influence of the sympathetic nervous system on the inflammation, accompanied by an up‐regulation of the sensory inputs into the joint, which may contribute to the maintenance of the disease.—Miller, L. E., Jüsten, H.‐P., Schölmerich, J., Straub, R. H. The loss of sympathetic nerve fibers in the synovial tissue of patients with rheumatoid arthritis is accompanied by increased norepinephrine release from synovial macrophages. FASEB J. 14, 2097–2107 (2000)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Neuropeptides on Production of Inflammatory Cytokines by Human Monocytes
Lotz, M., Vaughan, J. H., & Carson, D. A. (1988) · Science · doi:10.1126/science.2457950 · Cited by 915
Haskó, G., Szabó, C., Németh, Z. H., Kvetan, V, Pastores, S. M., & Vizi, E. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4634 · Cited by 536
Intraneuronal Substance P Contributes to the Severity of Experimental Arthritis
Levine, J. D., Clark, R., Devor, M., Helms, C., Moskowitz, M. A., & Basbaum, A. I. (1984) · Science · doi:10.1126/science.6208609 · Cited by 524
Bamji, S. X., Majdan, M., Pozniak, C. D., Belliveau, D. J., Aloyz, R., Kohn, J., Causing, C. G., & Miller, F. D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.4.911 · Cited by 506
Substance P Activation of Rheumatoid Synoviocytes: Neural Pathway in Pathogenesis of Arthritis
Lotz, M., Carson, D. A., & Vaughan, J. H. (1987) · Science · doi:10.1126/science.2433770 · Cited by 444
Sanders, V. M., Baker, R. A., Ramer-Quinn, D. S., Kasprowicz, D. J., Fuchs, B. A., & Street, N. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.9.4200 · Cited by 435
Elenkov, I. J., Papanicolaou, D. A., Wilder, R. L., & Chrousos, G. P. (1996) · PubMed · Cited by 419
Renz, H., Gong, J. H., Schmidt, A., Nain, M., & Gemsa, D. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.7.2388 · Cited by 394
Spengler, R. N., Allen, R. M., Remick, D. G., Strieter, R. M., & Kunkel, S. L. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.5.1430 · Cited by 388
Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors
Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., & Firestein, G. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3435 · Cited by 352
Substance P selectively activates TNF-alpha gene expression in murine mast cells
Ansel, J. C., Brown, J. R., Payan, D. G., & Brown, M. A. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.10.4478 · Cited by 343
Spengler, R. N., Chensue, S. W., Giacherio, D. A., Blenk, N., & Kunkel, S. L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.6.3024 · Cited by 269
Molecular therapeutics. Methotrexate and its mechanism of action
Cronstein, B. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780391203 · Cited by 265
Mapp, P. I., Kidd, B. L., Gibson, S. J., Terry, J. M., Revell, P. A., Ibrahim, N. B. N., Blake, D. R., & Polak, J. M. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90199-e · Cited by 200
Lieb, K., Fiebich, B. L., Berger, M., Bauer, J., & Schulze-Osthoff, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4952 · Cited by 191
The contribution of neurogenic inflammation in experimental arthritis
Levine, J. D., Moskowitz, M. A., & Basbaum, A. I. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.2.843 · Cited by 186
Dialogue between the CNS and the immune system in lymphoid organs
Straub, R. H., Westermann, J., Schölmerich, J., & Falk, W. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01297-3 · Cited by 159
Self-citationSemaphorins as Mediators of Neuronal Apoptosis
Shirvan, A., Ziv, I., Fleminger, G., Shina, R., He, Z., Brudo, I., Melamed, E., & Barzilai, A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730961.x · Cited by 154
Haskó, G., Nemeth, Z. H., Vizi, E. S., Salzman, A. L., & Szabó, C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00619-0 · Cited by 153
Laurenzi, M. A., Persson, M. A. A., Dalsgaard, C.-J., et al. (1990) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1990.tb02801.x · Cited by 152
Substance P enhances IL-2 expression in activated human T cells
Calvo, C., Chavanel, G., & Senik, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.11.3498 · Cited by 150
Semaphorin III can repulse and inhibit adult sensory afferents in vivo
Tanelian, D. L., Barry, M. A., Johnston, S. A., Le, T., & Smith, G. M. (1997) · Nature Medicine · doi:10.1038/nm1297-1398 · Cited by 141
The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine
Cronstein, B. N., Naime, D., & Firestein, G. S. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380804 · Cited by 137
Szabó, C., Haskó, G., Zingarelli, B., Nemeth, Z. H., Salzman, A. L., Kvetan, V., Pastores, S. M., & Vizi, E. S. (1997) · Immunology · doi:10.1046/j.1365-2567.1997.00137.x · Cited by 132
da Silva, J. A. P., & Carmo‐Fonseca, M. (1990) · PubMed · Cited by 115
Clinical response to regional intravenous guanethidine in patients with rheumatoid arthritis.
Levine, J. D., Fye, K. H., Heller, P. H., Basbaum, A. I., & Whiting-O'Keefe, Q. E. (1986) · PubMed · Cited by 96
Malfait, A., Malik, A. S., Marinova-Mutafchieva, L., Butler, D., Maini, R. N., & Feldmann, M. (1999) · PubMed · Cited by 96
Catecholamines increase monocyte TNF receptors and inhibit TNF through β2-adrenoreceptor activation
Guirao, X., Kumar, A., Katz, J. A., Smith, M. G., Lin, E., Keogh, C., Calvano, S. E., & Lowry, S. F. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1203 · Cited by 96
The Contribution of the Nervous System to Inflammation and Inflammatory Disease
Basbaum, A. I. (1991) · Developments in critical care medicine and anestesiology · doi:10.1007/978-94-011-3318-0_4 · Cited by 96
The contribution of the nervous system to inflammation and inflammatory disease
Basbaum, A. I., & Levine, J. D. (1991) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y91-096 · Cited by 95
Ahmed, M., Bjurhol, A., Schultzberg, M., Theodorsson, E., & Andris Kreicbergs, A. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380519 · Cited by 93
Green, P. G., Basbaum, A. I., Helms, C. A., & Levine, J. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4162 · Cited by 89
Stimulation of IL-2 production in murine lymphocytes by substance P and related tachykinins.
Rameshwar, P., Gascon, P., & Ganea, D. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2484 · Cited by 86
Sensitisation of articular afferents in normal and inflamed knee joints by substance P in the rat
Heppelmann, B., & Pawlak, M. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)13408-5 · Cited by 81
Sluka, K. A., Lawand, N., & Westlund, K. N. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.5.309 · Cited by 78
Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation
Boyle, D. L., Sajjadi, F. G., & Firestein, G. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390608 · Cited by 75
Effect of substance P on superoxide anion and IL-8 production by human PMNL.
Serra, M. C., Calzetti, F., Ceska, M., & Cassatella, M. A. (1994) · PubMed · Cited by 74
Bresnihan, B., Cunnane, G., Youssef, P. P., Yanni, G., FitzGerald, O., & Mulherin, D. M. (1998) · Rheumatology · doi:10.1093/rheumatology/37.6.636 · Cited by 74
Molecules making waves in axon guidance.Preprint
Varela‐Echavarría, A., & Guthrie, S. (1997) · Genes & Development · doi:10.1101/gad.11.5.545 · Cited by 67
Coderre, T. J., Chan, A., Helms, C. A., et al. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90184-p · Cited by 63
Lieb, K., Fiebich, B. L., Busse-grawitz, M., Hüll, M., Berger, T., & Bauer, J. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00034-3 · Cited by 60
Ritchie, P. K., Spangelo, B. L., Krzymowski, D. K., Rossiter, T. B., Kurth, E. J., & Judd, A. M. (1997) · Cytokine · doi:10.1006/cyto.1996.0153 · Cited by 55
Lorton, D., Bellinger, D. L., Duclos, M., Felten, S. Y., & Felten, D. L. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00150-6 · Cited by 49
Lombard, M., & Besson, J. (1989) · Brain Research · doi:10.1016/0006-8993(89)91393-0 · Cited by 46
Effect of three animal models of inflammation on nerve fibres in the synovium.
Mapp, P. I., Walsh, D. A., Garrett, N. E., Kidd, B. L., Cruwys, S., Polak, J. M., & Blake, D. R. (1994) · Annals of the Rheumatic Diseases · doi:10.1136/ard.53.4.240 · Cited by 44
Straub, R. H., Dorner, M., Riedel, J., Kubitza, M., van Rooijen, N., Lang, B., Schölmerich, J., & Falk, W. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.274.4.r997 · Cited by 29
Self-citation
Cited by
Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity
ELENKOV, I. J., & CHROUSOS, G. P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04229.x · Cited by 983
Cytokine Dysregulation, Inflammation and Well-Being
Elenkov, I. J., Iezzoni, D. G., Daly, A., Harris, A. G., & Chrousos, G. P. (2005) · Neuroimmunomodulation · doi:10.1159/000087104 · Cited by 502
The sympathetic nervous response in inflammation
Pongratz, G., & Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0504-2 · Cited by 427
Self-citationEnergy regulation and neuroendocrine–immune control in chronic inflammatory diseases
Straub, R. H., Cutolo, M., Buttgereit, F., & Pongratz, G. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02218.x · Cited by 382
Self-citationNeural Regulation of Hematopoiesis, Inflammation, and Cancer
Hanoun, M., Maryanovich, M., Arnal-Estapé, A., & Frenette, P. S. (2015) · Neuron · doi:10.1016/j.neuron.2015.01.026 · Cited by 265
Metadata
- Authors
- Miller, L. E., Jüsten, H., Schcölmerich, J., & Straub, R. H.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2000-10
- Volume
- 14
- Issue
- 13
- Pages
- 2097-2107
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2078127406
- Cited by
- 294
- References
- 46
- FWCI
- 5.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.